News | June 09, 2023
Lonza signs VPPA for solar power supply with Ignis
Under the terms of the VPPA, IGNIS will produce renewable energy equal to Lonza’s electricity needs across Switzerland and the European Union.
Under the terms of the VPPA, IGNIS will produce renewable energy equal to Lonza’s electricity needs across Switzerland and the European Union.
The new Biolys provides higher concentration of L-lysine
Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
One thousand times more soluble than L-cystine at neutral pH
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The collaboration between CORONA and Ferring will cater to patients across India
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
Subscribe To Our Newsletter & Stay Updated
